Skip to main content
    I

    InspireMD Inc (NSPR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.48
    +0.01 (+2.58%)

    Market Cap: $21.77M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(28/33)
    Avg Surprise
    +22.06%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.15
    Range$-0.16 - $-0.15
    3 analysts
    EPS Revisions
    3
    0
    7d
    3
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.19+17.9%
    60d ago$-0.19+17.9%
    30d ago$-0.19+17.9%
    7d ago$-0.19+17.9%
    Current$-0.15
    Revenue Consensus
    $2M
    Range$2M - $2M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.08
    Range$-0.10 - $0.40
    3 analysts
    Revenue Consensus
    $4M
    Range$3M - $4M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.08---
    Sep 26EST
    		-$-0.15---
    Jun 26
    Reported Aug 14
    		$-0.17$-0.20+15.00%Beat+34.6%
    Mar 26
    Reported May 4
    		$-0.16$-0.18+11.11%Beat+27.3%
    Dec 25
    Reported Mar 18
    		$-0.14$-0.19+26.32%Beat+26.3%
    Sep 25
    Reported Nov 4
    		$-0.17$-0.19+10.53%Beat-6.3%
    Jun 25
    Reported Aug 4
    		$-0.26$-0.26+0.00%Beat-18.2%
    Mar 25
    Reported May 9
    		$-0.22$-0.20-10.00%Miss-4.8%
    Dec 24
    Reported Mar 12
    		$-0.19$-0.20+5.00%Beat-18.8%
    Sep 24
    Reported Nov 12
    		$-0.16$-0.20+20.00%Beat-6.7%
    Jun 24
    Reported Aug 6
    		$-0.22$-0.19-15.79%Miss+8.3%
    Mar 24
    Reported May 14
    		$-0.21$-0.15-40.00%Miss+60.4%
    Dec 23
    Reported Mar 6
    		$-0.16$-0.19+15.79%Beat+73.3%
    Sep 23
    Reported Nov 6
    		$-0.15$-0.15+0.00%Beat+74.1%
    Jun 23
    Reported Aug 8
    		$-0.24$-0.30+20.00%Beat+59.3%
    Mar 23
    Reported May 15
    		$-0.53$-0.68+22.06%Beat+7.0%
    Dec 22
    Reported Mar 30
    		$-0.60$-0.84+28.57%Beat-13.2%
    Sep 22
    Reported Nov 8
    		$-0.58$-0.73+20.55%Beat-9.4%
    Jun 22
    Reported Aug 9
    		$-0.59$-0.73+19.18%Beat-28.3%
    Mar 22
    Reported May 10
    		$-0.57$-0.80+28.75%Beat-7.5%
    Dec 21
    Reported Mar 8
    		$-0.53$-0.78+32.05%Beat+55.8%
    Sep 21
    Reported Nov 9
    		$-0.53$-0.82+35.37%Beat+41.1%
    Jun 21
    Reported Aug 10
    		$-0.46N/A+95.13%Beat+84.7%
    Mar 21
    Reported May 11
    		$-0.53$-0.60+11.67%Beat+91.8%
    Dec 20
    Reported Mar 9
    		$-1.20$-0.97-23.71%Miss+86.0%
    Sep 20
    Reported Nov 9
    		$-0.90N/A+66.67%Beat+95.2%
    Jun 20
    Reported Aug 5
    		$-3.00$-5.25+42.86%Beat+87.4%
    Mar 20
    Reported May 12
    		$-6.45$-9.45+31.75%Beat+88.7%
    Dec 19
    Reported Mar 10
    		$-8.55$-8.55+0.00%Beat-71.0%
    Sep 19
    Reported Nov 12
    		$-18.90$-20.25+6.67%Beat-656.0%
    Jun 19
    Reported Aug 6
    		$-23.85$-30.00+20.50%Beat-218.0%
    Mar 19
    Reported May 14
    		$-57.30$-37.50-52.80%Miss-5205.6%
    Dec 18
    Reported Feb 19
    		$-5.00N/AN/ABeat+32.2%
    Sep 18
    Reported Nov 6
    		$-2.50N/A+98.32%Beat+99.9%
    Jun 18
    Reported Aug 6
    		$-7.50N/A+94.96%Beat-3471.4%
    Mar 18
    Reported May 7
    		$-1.08N/AN/ABeat-66.2%
    Dec 17
    Reported Feb 14
    		$-7.38N/AN/ABeat+99.5%
    Sep 17
    Reported Nov 7
    		$-4987.50N/A+91.56%Beat-
    Jun 17
    Reported Aug 8
    		$-0.21N/AN/ABeat-
    Mar 17
    Reported May 9
    		$-0.65N/AN/ABeat-
    Dec 16
    Reported Feb 16
    		$-1531.72$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.75EV/EBITDAN/A
    Price/FCF-0.83xFCF Yield-120.33%
    Profitability
    Profit Margin0.00%Operating Margin-816.00%
    ROE-202.80%ROIC-114.82%
    Financial Health
    Debt/Equity0.06xInterest CoverageN/A
    Current Ratio3.80xQuick Ratio3.52x
    Trading Statistics
    Beta0.83Avg Volume111.27K
    52-Week High$2.4152-Week Low$0.46

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.52
    SMA 20$0.61
    SMA 50$0.75
    SMA 200$1.14
    EMA 10$0.53
    EMA 20$0.59
    EMA 50$0.70
    EMA 200$1.12

    MACD

    Line: -0.08Signal: -0.07Hist: -0.01

    ADX

    ADX: 36.5+DI: 12.3-DI: 21.0

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down96.0
    PSAR$0.57

    Bollinger Bands

    Upper Band$0.83
    Lower Band$0.40
    %B Position7079%(Upper)
    Band Width0.19

    RSI (14-Day)

    Oversold
    26.4

    Momentum Oscillators

    Stoch %K8.4
    Stoch %D10.5
    Williams %R-92.0
    ROC (10d)-22.5%
    Momentum-0.14
    CCI (20d)-97.8
    MFI (14d)22.5

    Volatility Measures

    ATR (14d)$0.07(14.3%)
    StdDev (20d)0.11
    Hist Vol70.1%(High)

    Volume Flow

    VWAP$0.49
    OBV-15.2M
    AD Line-16.0M
    CMF (20d)-0.447

    Volume Metrics

    Avg Vol (20d)119.6K
    Vol Ratio0.5x(Low)
    VWMA (20d)$0.58

    Pivot Points

    R3$0.53
    R2$0.52
    R1$0.49
    Pivot Point$0.48
    S1$0.45
    S2$0.44
    S3$0.41

    Advanced Oscillators

    TSI-49.12
    Ultimate Osc27.1
    KST-340.53

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.77M$3.40M$3.15M$2.52M$1.78M$1.53M$1.95M$1.81M$1.74M$1.51M$1.76M$1.56M
    Cost of Revenue$2.54M$2.71M$1.97M$1.66M$1.47M$1.24M$1.48M$1.40M$1.41M$1.22M$1.26M$1.12M
    Gross Profit$-774,000$687,000$1.18M$864,000$313,000$292,000$469,000$414,000$331,000$292,000$505,000$438,000
    Operating Expenses$13.67M$14.66M$13.26M$13.91M$13.33M$11.75M$9.84M$8.88M$8.59M$7.71M$6.31M$6.08M
    R&D$4.29M$4.76M$3.48M$3.63M$3.83M$4.06M$3.69M$3.92M$3.40M$2.63M$2.04M$2.11M
    SG&A$4.16M$4.72M$4.55M$5.89M$5.33M$4.94M$4.23M$3.49M$3.75M$3.84M$2.97M$3.09M
    Operating Income$-14,445,000$-13,978,000$-12,084,000$-13,051,000$-13,019,000$-11,460,000$-9,367,000$-8,462,000$-8,260,000$-7,414,000$-5,808,000$-5,639,000
    Interest Income$0$289,000$386,000$343,000$0$294,000$252,000$572,000$351,000$382,000$468,000$461,000
    Interest Expense$0$0$0$0$132,000$0$0$0$0$0$125,000$0
    Income Before Tax$-14,324,000$289,000$-11,698,000$-12,708,000$-13,151,000$-11,166,000$-9,115,000$-7,890,000$-7,909,000$-7,032,000$-5,340,000$-5,178,000
    Income Tax Expense$0$0$63,000$0$0$0$59,000$0$0$25,724$65,000$-58,000
    Net Income$-14,324,000$289,000$-11,761,000$-12,708,000$-13,151,000$-11,166,000$-9,174,000$-7,890,000$-7,909,000$-7,032,000$-5,405,000$-5,178,000
    EBITDA$-14,166,000$438,000$-11,555,000$-12,580,000$-12,912,000$-11,068,000$-9,040,000$-7,820,000$-7,843,000$-6,963,000$-5,279,000$-5,120,000
    EBIT$-14,324,000$289,000$-11,698,000$-12,708,000$-13,019,000$-11,166,000$-9,115,000$-7,890,000$-7,909,000$-7,032,000$-5,340,000$-5,178,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NSPR

    News

    InspireMD (NASDAQ:NSPR) Will Have To Spend Its Cash Wisely

    InspireMD (NASDAQ:NSPR) faces a challenging financial outlook, with a cash burn of US$42m against US$30m in cash...

    Simply Wall Street•10/2/26•Bearish

    Form 4 InspireMD Inc For: 27 September By Investing.com

    This article is a brief report from Investing.com indicating that a Form 4 for InspireMD Inc. was filed on September 27. A Form 4 is a document filed with the SEC by company insiders, such as officers, directors...

    Investing.com UK•9/27/26•Neutral

    Form 4 InspireMD Inc For: 26 September By Investing.com

    This article from Investing.com announces the filing of Form 4 for InspireMD Inc. on September 26. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is...

    Investing.com Nigeria•9/27/26•Neutral

    InspireMD (NSPR) director Gary S. Roubin acquired and disposed of warrants with different exercise prices.

    InspireMD director Gary S. Roubin reported both acquisitions and dispositions of Series J and Series K warrants on September 18...

    Stock Titan•9/24/26•Neutral

    InspireMD (NSPR) director Michael Berman reports acquiring and disposing of warrants at two exercise prices.

    InspireMD director Michael Berman reported indirect transactions on September 18, 2026, involving Series J and Series K warrants. He disposed of and acquired 30,625 Series J warrants and 61,248 Series K warrants each...

    Stock Titan•9/23/26•Neutral

    NSPR Valuation and Fair Value

    P/E
    -0.8x
    Forward P/E
    11.7x
    P/FCF
    -0.8x
    PEG
    0.0x
    P/B
    1.1x
    See GNG's fair value

    NSPR Profitability: Margins, ROIC and FCF

    Gross margin
    18.1%
    Operating margin
    -816.0%
    Net margin
    0.0%
    ROIC
    -114.8%
    ROE
    -202.8%
    FCF margin
    -391.7%
    FCF yield
    -120.3%

    NSPR Competitors

    CompanyTicker
    Heartbeam IncBEAT
    Universe Pharmaceuticals IncUPC
    TherapeuticsMD IncTXMD
    PAVmed IncPAVM
    Context Therapeutics IncCNTX
    Cocrystal Pharma IncCOCP
    Galecto IncGLTO
    Scilex Holding CompanySCLX

    Sector: Healthcare

    NSPR Analyst Ratings

    Consensus
    Strong Buy
    Analysts
    3
    Strong Buy
    2
    Buy
    1
    Hold
    0
    Sell
    0
    Strong Sell
    0

    NSPR Bull Case vs Bear Case

    Bull case

    • NSPR beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • NSPR's quarterly revenue changed -0.4% year over year.

    NSPR Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    9.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.15
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    3 up, 0 down

    Frequently Asked Questions About NSPR

    Does NSPR pay dividends?

    InspireMD Inc (NSPR) does not currently pay a regular dividend.

    What is NSPR's market cap?

    InspireMD Inc (NSPR) has a market capitalization of $21.77M with a current stock price of $0.48.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In